Search results
Results from the WOW.Com Content Network
The CDC’s new COVID-19 vaccine recommendations suggest a second dose of the updated COVID-19 vaccine for people who are 65+, as well as those who are moderately or severely immunocompromised ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.
The CDC recommends Pfizer (PFE)/ BioNTech's (BNTX) COVID-19 vaccine booster shots for older adults only but not for high-risk workers.
The final recommendation from director Mandy Cohen comes after an expert advisory group to the CDC on Wednesday said U.S. adults aged 65 and older should get a second annual COVID-19 shot this ...
ACIP members also voted to recommend adults 65 and older get a second dose of the updated COVID-19 vaccine this fall. Eligible patients should ask their provider the best time to take an ...
On May 4, 2021, Biden announced a new target of having at least 70% of U.S. adults receive one vaccine dose by July 4. [134] On May 10, 2021, the FDA granted emergency use authorization for the Pfizer vaccine for use on adolescents aged 12–15, making the United States the second country in the world, after Canada, to do so. [135]
On 16 April 2021, the FDA revoked the emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.
The FDA authorized a booster shot of the Pfizer vaccine for people 65 and up and high-risk individuals, following its advisory committee's recommendation.